The purpose of this cross-sectional study was to examine the risk associations between obesity indexes [body mass index (BMI) and waist circumference (WC)], cardiovascular risk factors [plasma glucose and lipids, blood pressure and urinary albumin excretion (UAE)] and morbidity conditions (Type 2 diabetes mellitus, hypertension, dyslipidaemia and/or albuminuria) in Hong Kong Chinese. Seven-hundred and two Hong Kong Chinese subjects (18-65 years of age, 59.4% of whom had at least one morbidity condition) were recruited from the Prince of Wales Hospital, Hong Kong SAR. The measurements taken of the subjects included: height; weight; waist and hip circumferences; blood pressure; fasting plasma glucose and lipids; and 24-h UAE. The mean BMI was 22.4 and 25.7 kg m -2 in healthy subjects and patients, respectively. The mean WC measurements of healthy subjects and patients were 77.1 and 86.4 cm in males and 71.0 and 81.8 cm in females, respectively. There were increasing trends between obesity indexes and the severity of cardiovascular risk factors and the prevalence of morbidity conditions (all P-values for trend <0.05). Using 19.0-20.9 kg m -2 and <70 cm as a referent, subjects with a BMI of ≥25.0 kg m -2 (in both sexes) and/or a WC of ≥85 cm in males and ≥75 cm in females had an age-adjusted odds ratio between 3.2 and 4.4 for the occurrence of at least one morbidity condition. Patients with a greater number of comorbidities also had higher BMI and WC measurements (all P-values for the trend were <0.05 with adjustment for age and gender). Hence, despite Hong Kong Chinese being less obese than Caucasians, the intimate relationships among obesity, cardiovascular risk factors and morbidity conditions remain. Our data support using lower BMI and WC levels to define obesity and its associated health risks rather than using the criteria established from Caucasians who generally have larger body frames.
Introduction
Owing to its close associations with conditions that have significant morbidity and early mortality (1, 2) , the World Health Organization (WHO) has recently defined obesity as a disease (3) . In light of the rapidly increasing prevalence of obesity throughout the world (4, 5) , obesity has also been described as a global epidemic (3) . Body mass index (BMI) is a simple anthropometric measurement of weight (kg) corrected by squared height (m 2 ) and is the most widely used index for assessing overweight or obesity in a large population. In Caucasians, the optimal BMI range lies between 19 and 25 kg m -2 , which is associated with the lowest health risk (6) (7) (8) (9) . Subjects with a BMI above this optimal range have increased odds ratios for morbidities (such as Type 2 diabetes mellitus, hypertension and hyperlipidaemia) and mortality.
The United States (US) National Diabetes Data Group defined obesity as a BMI of ≥27 kg m -2 for men and ≥25 kg m -2 for women (10) , but in the US National Health and Nutrition Examination Surveys (NHANES), overweight was defined as a BMI of ≥27.8 kg m -2 for men and ≥27.3 kg m -2 for women (4) . According to the most recent WHO classification of obesity (3), a BMI of 18.5-24.9 kg m -2 is defined as the optimal or normal range, and BMIs of ≥25 and ≥30 kg m -2 are classified as overweight and obese, respectively. Using the criterion of BMI ≥30 kg m -2 , the prevalence of obesity is approximately 10-20% and 15-25% in European men and women, respectively (11) . By contrast, the prevalence of obesity using the same criterion in Asian populations is less than 3% in Japan (12, 13) and China (13) . Based on these definitions, Asian populations, such as Chinese, are often considered as non-obese populations.
However, a recent Japanese report has highlighted the substantial underestimation of the risk of relative obesity in Asians if the present WHO recommendations are applied to non-Caucasian populations. In Japanese adults, a BMI greater than 22.3 kg m -2 was associated with increased atherogenic risk factors (14) . In addition, the recommended criteria used by the authors to define overweight (24.7kgm -2 for men and 22.6 kg m -2 for women) were considerably lower than those in Western countries (15) . Genetic, environmental and ethnic factors can all influence the degree of risks associated with excess body weight. Despite interethnic differences in BMI distributions, the relative and attributable risks of morbidity and mortality associated with different degrees of overweight will probably hold true within that population. Consequently, it is more appropriate to define the prevalence of obesity in Asian populations using ethnic-specific values of BMI. Such an approach needs validation from data collected from various Asian populations. In Hong Kong, based on a recent large-scale populationbased survey (16) , the prevalence of obesity (≥30 kg m -2 ) was 5.4% and 7.0% in men and women, and approximately 33% of the subjects had a BMI of ≥25 kg m -2
. These figures are similar to those reported in Japanese (12) but much lower than those in European (13) populations. In a Hong Kong Chinese population of working age, BMI and waist-to-hip ratio were amongst the strongest predictors for glucose intolerance (17) . These obesity indexes also explained most of the variance in different components of the metabolic syndrome, including blood pressure, plasma glucose, triglycerides, insulin and (to a lesser extent) microalbuminuria (18, 19) . In Hong Kong, the mean BMI of young Type 2 diabetic patients (mean age 33 years) was 26.3kgm -2 (20) . This figure is lower than the respective BMI in Caucasian diabetic patients and similar to that of the Caucasian general population (20) .
In this study, we examined the relationships between BMI, waist circumference (WC), cardiovascular risk factors [including plasma glucose and lipids, blood pressure, urinary albumin excretion (UAE)] and morbidity conditions (including the prevalence of diabetes, hypertension, dyslipidaemia and albuminuria) in a cohort of Hong Kong Chinese subjects aged between 18 and 65 years. We also estimated the odds ratios associated with morbidity condition(s) across different categories of BMI and WC.
Subjects and methods

Subjects
The study cohort consisted of 417 (59.4%) patients with Type 2 diabetes mellitus and/or hypertension and/or dyslipidaemia (according to the WHO 1999 criteria; see ref. 21 ) and/or albuminuria, and who were recruited from the medical out-patient clinics at the Prince of Wales Hospital. Two-hundred and eighty five (40.6%) healthy volunteers, mainly hospital staff or friends of investigators, were studied at the Clinical Pharmacology Studies Unit. The relationship between BMI and various cardiovascular risk factors have been described in brief in a local medical journal (22) . The present report represents a detailed analysis based on BMI and WC categories and their relationships with various cardiovascular risk factors and morbidity conditions. All subjects were Hong Kong Chinese aged between 18 and 65 years and had normal renal function (plasma creatinine <150 µmol L -1 ). The hypertensive or dyslipidaemic patients had received no medication for at least four weeks before the start of the study. None of the diabetic patients received insulin treatment or lipid-lowering agent and their usual medications were omitted on the morning of the study day. The study was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong. All subjects gave written, informed consent.
On the study day, the subjects attended the Unit after at least 8 h of overnight fast. Height, weight, waist (the minimum circumference between the umbilicus and xiphoid process) and hip (the maximum circumference around the buttocks and symphysis pubis) circumferences were recorded. BMI was calculated as weight (kg) divided by height (m) squared as an index of general obesity. WC and the waist-to-hip ratio were calculated as the indices of central obesity. Blood pressure was taken as the mean of three readings separated by a 1-min interval by a Dinamap 8100 automated blood pressure monitor (Critikon Inc., Tampa, FL) after at least 5 min in the sitting position. Venous blood was sampled for measurements of fasting plasma glucose, serum lipid concentrations [total cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride] and plasma creatinine. A 24-h urine sample was collected for measurements of UAE using boric acid preservative (23) . All assays were performed in the Department of Chemical Pathology at the Prince of Wales Hospital, as previously described (24) .
Definitions
The four morbidity conditions were defined as Type 2 diabetes mellitus, hypertension, dyslipidaemia and increased albuminuria (micro/macroalbuminuria). Type 2 diabetes mellitus was defined as a fasting plasma glucose of ≥7.0 mmol L -1 and/or a 2-h postglucose loading plasma glucose level of ≥11.1 mmol L -1 , using the WHO 1999 criterion (21) . Subjects were considered to be hypertensive if they were on antihypertensive drugs or had a blood pressure measurement of ≥140/90 mmHg, according to the criteria of the WHO 1999 or Joint National Committee (21, 25 (26) (27) (28) . Based on the 24-h urine collection, albuminuria was defined as a UAE of ≥30 mg d -1 (29) .
Statistical analysis
All statistical analyses were performed using the Statistical Package for Social Sciences (SPSS for Windows, version 9.0). All P-values were two-sided. Serum triglyceride and 24-h UAE were logarithmically transformed owing to skewed distributions. All data are expressed as mean values ± standard deviation (SD), or as geometric mean ¥/∏ antilog SD or percentage as appropriate. .0 cm). The odds ratios were calculated using logistic regression models with adjustment for age. In all analyses, the first category of <70 cm was used a referent for WC, while the second category of 19.0-20.9 kg m -2 instead of <19.0 kg m -2 was used as a BMI referent. The latter was not chosen because it was far below the recommended BMI range in the current WHO 1998 guidelines (3) and might be associated with excess health risks owing to cigarette smoking, malnutrition or subclinical diseases (30) . To test for a linear trend across BMI or WC categories, the categories were entered as an ordinal variable in the logistic regression models. In separate models, to test for a quadratic trend, a quadratic term for BMI (i.e. BMI 
Results
Clinical characteristics
The baseline clinical and biochemical characteristics of the study participants are shown in Table 1 . Approximately 26%, 28%, 30% and 12% had the following morbidity condition(s): Type 2 diabetes mellitus, hypertension, dyslipidaemia and increased albuminuria, respectively. Men were heavier and had higher WC, waist-to-hip ratio, blood pressure and fasting plasma glucose, creatinine and triglyceride concentrations and a lower HDL cholesterol level than women (all P-values <0.05). The prevalence of dyslipidaemia was also higher in men than women. The patient group (n = 417) had a higher BMI (25.7 ± 4.8 kg m -2 vs. 22.4 ± 3.2 kg m -2 , P < 0.0001) and WC (86.4 ± 9.9 vs. 77.1 ± 7.6 cm in males; 81.8 ± 10.3 vs. 71.0 ± 8.2 cm in females, all P < 0.001) than healthy volunteers (n = 285).
Comparisons between patients with increasing number of comorbidities
Many of the patients had multiple comorbidities, and patients with a greater number of comorbidities also had higher BMI and WC levels (all P-values for the trend were <0.05 after adjustment for age and gender, Fig. 1 ). For those having zero, one or at least two comorbidities, the BMI levels were: 24.5 ± 4.7 (n = 75), 26.0 ± 4.6 (n = 63) and 27.2 ± 3.6 kg m -2 (n = 46) in diabetic patients; 25.7 ± 4.1 (n = 66), 26.1 ± 4.2 (n = 77) and 27.2 ± 3.6kgm
(n = 51) in hypertensive patients; and 24.6 ± 3.6 (n = 75), 25.5 ± 4.3 (n = 77) and 27.4 ± 3.5 kg m -2 (n = 59) in obesity reviews Data are expressed as means ± standard deviation (SD), geometric means ¥/÷ antilog SD or percentage. *P < 0.05, †P < 0.001 for between-group comparison using c 2 -or unpaired t-tests. ‡Four morbidities were defined as: Type 2 diabetes mellitus, hypertension, dyslipidaemia and increased albuminuria (micro/macroalbuminuria). HDL, high-density lipoprotein; LDL, low-density lipoprotein. Comparisons between subjects with different ranges of BMI or WC With increasing levels of BMI (Table 2 ) and WC (Tables 3  and 4) , there were increasingly adverse cardiovascular risk Data are expressed as means ± standard deviation (SD), geometric means ¥/÷ antilog SD or percentage. *Diabetics were excluded from the analysis as a result of antidiabetic treatment. †Linear or ‡quadratic trend using polynomial analysis of variance (ANOVA) or c 2 for the trend. §Four morbidities were defined as: Type 2 diabetes mellitus, hypertension, dyslipidaemia and increased albuminuria (micro/macroalbuminuria). HDL, high-density lipoprotein; LDL, low-density lipoprotein.
profiles, as reflected by a high fasting plasma glucose concentration, high blood pressure, 24-h UAE, high triglyceride and low HDL cholesterol (all P-values for the trend were <0.05). There were also increasing prevalence rates of comorbidities with increasing values of BMI or WC levels (in all analyses P-values for the trend were <0.05).
Odds ratios of comorbidities across increasing BMI or WC categories
Using a BMI range of 19.0-20.9 kg m -2 and WC of <70 cm as the referent (odds ratio = 1.0), there were increasing trends for most of the comorbidities across increasing degrees of BMI or WC in both sexes (all P-values for the quadratic trend were <0.01). The odds ratios for subjects in the BMI category of 23.0-24.9 kg m -2 for having at least one morbidity condition was 2 compared to those within the referent range (Fig. 2) . The odds ratios further increased from 3.2 to 59.8 in males and from 3.6 to 11.3 in females when BMI categories increased from 25.0 to ≥29.0 kg m -2 , respectively (all P-values <0.03). Male subjects with WC levels of ≥85.0 cm had an odds ratio of 4.1 and female subjects with WC levels of ≥75 cm had an odds ratio of 4.4 for having at least one morbidity condition, compared to those in the referent group (Fig. 3) . These age-adjusted odds ratios increased further to 4.9, 5.2 and 49.1 for males with WC categories of 80.0-84.9, 85.0-89.9 and ≥90. The respective odds ratios were 6.7, 5.7, 14.5 and 27.2 for females with WC ranges of 75.0-79.9, 80.0-84.9, 85.0-89.9 and ≥90 cm compared to those with the lowest waist circumference (<70 cm). The odds ratios for the occurrence of albuminuria were greatly increased to 55.1 in males with a WC of ≥90 cm and to 32.1 in females with a WC of ≥75 cm.
Discussion
Obesity is a heterogeneous disease associated with lifethreatening comorbidities such as diabetes, hypertension and dyslipidaemia (1). These three diseases account for a huge proportion of the burden of health care cost to society (31) (32) (33) . Based on findings from the US, Wolf & Colditz suggested a healthy body weight, from an economic standpoint, to represent a BMI of <25 kg m -2 (34) . In most parts of the world, there are increasing trends of obesity (4, 13, 35) . In Hong Kong, based on two large-scale popu- Data are expressed as means ± standard deviation (SD), geometric means ¥/÷ antilog SD or percentage. *Diabetics were excluded from the analysis as a result of antidiabetic treatment. †Linear or ‡quadratic trend using polynomial analysis of variance (ANOVA) or c 2 for the trend. §Four morbidities were defined as: Type 2 diabetes mellitus, hypertension, dyslipidaemia and increased albuminuria (micro/macroalbuminuria). HDL, high-density lipoprotein; LDL, low-density lipoprotein.
lation-based studies, the prevalence of overweight (using BMI ≥25 kg m -2 ) increased from 28% to 38% in men, and from 28% to 34% in women in 1990 (17, 19) and 1995 (16) , respectively. Although these prevalence rates were not directly comparable as a result of different sampling methods, they were in accordance with the rising trend of childhood obesity (36, 37) in our population.
In Hong Kong, the mean BMI of both men and women was only 23-24 kg m -2 (16, 17) . This value is similar to that reported in other Asian populations such as Japanese (38, 39) and Singaporeans (40) . In the present study, the mean BMI of our healthy subjects was 22.4 kg m -2 (22.4 and 22.5 kg m -2 in males and females) whereas that of patients (with diabetes mellitus, hypertension, dyslipidaemia and/or albuminuria) was 25.7 kg m -2 (25.4 and 25.9 kg m -2 in males and females). In these subjects with multiple morbidities, their BMI of 26 kg m -2 was much lower than the average BMI of 28 kg m -2 in Caucasian patients (41) (42) (43) . By contrast, this value was closer to the average BMI of Caucasian general populations (44) (45) (46) .
Despite this apparently low degree of obesity, there were clear relationships between BMI and multiple cardiovascular risk factors and comorbidities. Consistent with the 1998 WHO recommended BMI cut-off value of ≥25 kg m Our data show that a BMI of ≥25 kg m -2 in both sexes, a WC of ≥85 cm in males and a WC of ≥75 cm in females were associated with increased health risks. These findings are similar to those found in 1513 Hong Kong Chinese of working age in whom a BMI of 24 kg m -2 in both sexes, a WC of 82 cm in males and a WC of 76 cm in females have been suggested as the cut-off values to define obesity (47) . These two studies therefore independently support the recent WHO/IASO/IOTF suggestion to consider using lower obesity measurements in Asians to guide health care professionals to promote healthy lifestyles and weight control (48) .
In view of the non-random nature of the selection, our findings may not be generalized easily. Given the small sample size, we also did not perform the analysis in separate age cohorts. Nonetheless, in this cohort of Hong Kong Chinese subjects with an age-range of 18-65 years, the similar increasing trends of cardiovascular risk factors and comorbidities across ascending BMI categories were generally observed in both sexes. However, one caveat relates to our lack of information on factors such as smoking and other subclinical diseases that may be associated with low BMI. In this respect, we used 19-20.9 kg m -2 rather than the lowest BMI of 19.0 kg m -2 as the referent value. Despite these limitations, our data still support the continuous relationship between morbidities and BMI from a level beginning at 23 kg m In agreement with other Asian data (38-40), our findings confirmed that Hong Kong Chinese exhibited lower BMI distributions than those seen in Western countries (44) (45) (46) . Our findings also accorded with the report from Japanese experts (14) that an increased health risk was apparent at a BMI of 23 kg m -2 with a further increase when the BMI exceeded 25 kg m ferences in BMI distributions, a value of 22 kg m -2 has been consistently reported to be associated with the lowest morbidity or mortality in studies which include analyses of Caucasians (49) (50) (51) .
In conclusion, the distribution of BMI and the associations of BMI categories with cardiovascular risk factors and related morbidities in Hong Kong Chinese were similar to those in other Asian populations, such as Japanese, but in contrast to other ethnic populations, such as Caucasians. Our data also support using BMI (for example, £23 kg m -2 ) and WC levels (for example, £85 cm and £75 cm for males and females, respectively) lower than the WHO 1998 recommendation (BMI £25 kg m Age-adjusted odds ratios of the occurrence, in males (n = 274, ᭹) and females (n = 428, ), of (1) Type 2 diabetes mellitus; (2) hypertension; (3) dyslipidaemia; (4) albuminuria; and (5) at least one of the above morbidity conditions. In all cases, the reference category (R) was body mass index (BMI) ranging from 19.0 to 20.9 kg m -2. *P < 0.01, **P < 0.0001 for the quadratic trend. Age-adjusted odds ratios of the occurrence, in males (n = 274, ᭹) and females (n = 428, ), of (1) Type 2 diabetes mellitus; (2) hypertension; (3) dyslipidaemia; (4) albuminuria; and (5) at least one of the above morbidity conditions. In all cases, the reference category (R) was waist circumference of <70 cm. *P < 0.01, **P < 0.0001 for the quadratic trend.
hypertension, dyslipidaemia, coronary heart disease and cancer, which are closely associated with overweight/ obesity, these definitions will facilitate the development of a more appropriate preventive strategy to combat these health care problems which are reaching epidemic proportions in Asia (52) .
